Back to Main

TetraLogic prices relaunched IPO at $7

By: Renaissance Capital
Posted: 12/12/2013 7:26:00 AM
Referenced Stocks: TLOG

TetraLogic Pharmaceuticals, which is developing small molecule therapeutics for the treatment of cancer, raised $50 million by offering 7.2 million shares at $7. TetraLogic Pharmaceuticals plans to list on the NASDAQ under the symbol TLOG. TetraLogic Pharmaceuticals initially filed confidentially on 9/16/2013. Oppenheimer & Co., Guggenheim Securities and Needham & Co. acted as lead managers on the deal.